A South African clinical trial has found a new HIV treatment regimen causes significantly less weight gain than the standard dolutegravir treatment.
Spread the loveFor years, the quest for effective, sustainable weight loss has felt like an uphill battle for millions. Diets come and go, exercise fads burn bright and then fade, and for many, the ...
The federal government is launching a clinical trial to determine whether a popular class of weight-loss and diabetes ...
A new approach to defining obesity could help physicians better determine which patients need more intensive treatment by ...
The VA is launching a new clinical trial to test whether blockbuster GLP-1 drugs used for weight loss and type 2 diabetes can ...
For a growing number of Americans on GLP-1 weight loss medications such as Wegovy and Zepbound, staying on treatment has ...
An unlicensed semaglutide-based product that is administered under the tongue is being marketed to private doctors in the UK despite the branded medicine's manufacturer warning of safety concerns.
Novo Nordisk said on Friday its experimental cardiovascular drug failed to show benefit in a late-stage study, dealing a ...
Peptides have become one of the hottest trends in wellness, with promises like faster muscle recovery and healthier aging.
Spread the loveImagine a world where a medication that costs over a thousand dollars a month suddenly becomes accessible for a mere fifty bucks. Sounds almost too good to be true, doesn’t it? Well, ...
Family-centered behavioral therapy induced greater reductions in median BMI than standard of care for children and adolescents with obesity, according to findings from the TEAM UP trial published in ...
The American Society for Nutrition and The Obesity Society recently announced a partnership that offers opportunities for discounted pricing and will advance clinical practice.According to a press ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results